ImmunityBio Inc.
IBRX | NASDAQ
$8.87
+$0.42 (+4.97%)
Sep 22, 2026, 10:26 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.63B | -854.57M | -351.45M | -348.67M | -367.15M | -409.18M | -413.65M | -587.88M | -597.71M | -601.34M | -583.79M | -458.7M | -474.06M | -430.44M | -416.68M | -399.61M | -377.1M | -370.8M | -347.59M | -324.1M | -301.28M | -264.43M |
Depreciation & Amortization | 20.98M | 16.08M | 15.53M | 15.8M | 16.29M | 16.81M | 17.54M | 17.96M | 29.56M | 29.84M | 29.97M | 30.63M | 23.59M | 23.72M | 23.5M | 21.93M | 16.62M | 15.79M | 14.3M | 12.87M | 12.74M | 12.25M |
Stock-Based Compensation | 42.48M | 35.44M | 36.81M | 37.1M | 35.71M | 35.7M | 34.43M | 38.17M | 45.13M | 46.55M | 49.16M | 45.74M | 41.92M | 41.03M | 40.18M | 41.01M | 44.22M | 51.91M | 57.18M | 47.67M | 34.55M | 17.01M |
Other Working Capital | 13.66M | 7.31M | -7.6M | -13.79M | -10.65M | -11.05M | -5.62M | -25.37M | -31.8M | -24.76M | 10.45M | 26.3M | 36.92M | 2.18M | -16M | -12.21M | -27.72M | -5.57M | -15.39M | -4.37M | 12.66M | 11M |
Other Non-Cash Items | 1.23B | 541.46M | 48.51M | 26.84M | 14.08M | 24.07M | -10.14M | 144.71M | 141.57M | 160.38M | 131.2M | 14.26M | 36.66M | 15.51M | 31.06M | 30.46M | 36.22M | 22.56M | 19.85M | 10.32M | 16.67M | 23.08M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -4K | -4K | -4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -28.15M | -32.79M | -54.33M | -50.76M | -48.48M | -37.56M | -19.42M | -34.33M | -28.55M | -24.86M | 6.71M | 25.87M | 36.49M | 3.29M | -15.56M | -12.21M | -30.49M | -8.34M | -18.16M | -7.14M | 12.66M | 11M |
Operating Cash Flow | -356.5M | -294.39M | -304.94M | -319.7M | -349.56M | -370.16M | -391.24M | -421.36M | -410M | -389.43M | -366.76M | -342.21M | -335.41M | -346.89M | -337.51M | -318.42M | -310.54M | -288.88M | -274.42M | -260.38M | -224.66M | -201.09M |
Capital Expenditures | -9.13M | -4.92M | -4.25M | -5.09M | -7.11M | -6.75M | -6.89M | -12.73M | -15.62M | -23.42M | -30.58M | -41.56M | -51.82M | -59.24M | -78.16M | -69.63M | -61.73M | -53.83M | -33.56M | -22.46M | -16.47M | -8.44M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -1M | -1M | -1M | -1M | n/a | n/a | 56K | 1.06M | 1.06M | 1.06M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -688.65M | -390.37M | -241.37M | -201.84M | -22M | -92.7M | -140.97M | -135.04M | -134.3M | -48.61M | -402K | -255K | -255K | -177K | -19K | n/a | -2.48M | -2.48M | -2.48M | -2.48M | n/a | n/a |
Sales Maturities Of Investments | 389.22M | 209.7M | 95.82M | 23.38M | 92.96M | 127.96M | 136.61M | 128.94M | 59.37M | 24.37M | 10.47M | 158K | 158K | 158K | 56K | n/a | 599K | 599K | 599K | 599K | n/a | n/a |
Other Investing Acitivies | -406K | -406K | -406K | -34K | n/a | n/a | n/a | n/a | -9.96M | -9.96M | -10.01M | -11.01M | 13.71M | 146.33M | 104.42M | -21.98M | -16.25M | -130.33M | -49.44M | 84.81M | 9.73M | 6.48M |
Investing Cash Flow | -308.56M | -185.58M | -149.8M | -183.54M | 62.85M | 27.51M | -12.25M | -19.83M | -100.49M | -57.61M | -30.47M | -51.61M | -37.15M | 88.13M | 27.3M | -91.61M | -79.86M | -186.04M | -84.89M | 60.46M | -6.75M | -1.96M |
Debt Repayment | 76.14M | 2.9M | 2.86M | 48K | 38K | 21K | n/a | 192.68M | 391.68M | 421.54M | 451.39M | 308.38M | 233.73M | 203.9M | 174.07M | 422.84M | 298.5M | 298.5M | 338.5M | 40M | 40M | 40M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.46M | -1.46M | -1.46M | -1.46M | n/a | n/a | -372K | -852K | -852K | -852K | -3.1M | -2.64M | -3.13M | -3.17M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -16.46M | -9.47M | -2.81M | -2.54M | -2.69M | 142.92M | 154.37M | 153.68M | 193.96M | 48.74M | 38.27M | 39.61M | -724K | -814K | -509K | 27.64M | 28.73M | 127.08M | 128.13M | 100.45M | 163.42M | 152.46M |
Financial Cash Flow | 720.71M | 625.15M | 400.24M | 452.28M | 294.34M | 270.42M | 281.63M | 375.24M | 597.16M | 491.68M | 558.34M | 467.74M | 354.23M | 310.8M | 233.61M | 449.63M | 368.3M | 466.65M | 505.44M | 179.73M | 200.29M | 189.3M |
Net Cash Flow | 55.67M | 145.15M | -54.48M | -50.96M | 7.7M | -72.23M | -121.88M | -66M | 86.61M | 44.56M | 160.82M | 73.81M | -18.39M | 52.24M | -76.32M | 39.78M | -21.91M | -8.29M | 146.19M | -20.16M | -31.2M | -13.98M |
Free Cash Flow | -365.63M | -299.31M | -309.19M | -324.79M | -356.66M | -376.91M | -398.12M | -434.1M | -425.62M | -412.85M | -397.34M | -383.77M | -387.23M | -406.13M | -415.67M | -388.06M | -372.27M | -342.71M | -307.98M | -282.85M | -241.13M | -209.52M |
Adj. Free Cash Flow | -408.11M | -334.75M | -346M | -361.89M | -392.38M | -412.61M | -432.56M | -472.26M | -470.75M | -459.4M | -446.5M | -429.51M | -429.15M | -447.17M | -455.85M | -429.06M | -416.49M | -394.61M | -365.16M | -330.52M | -275.68M | -226.53M |
Maintenance CapEx | -7.08M | -1.79M | n/a | n/a | n/a | n/a | -1.26M | -1.26M | -6.94M | -13.55M | -12.29M | -31.22M | -25.55M | -34.88M | -62.23M | -43.3M | -51.33M | -43.42M | -23.16M | -22.46M | -14.43M | -6.38M |
Growth CapEx | -2.05M | -3.13M | -4.25M | -5.09M | -7.11M | -6.75M | -5.63M | -11.47M | -8.68M | -9.87M | -18.29M | -10.34M | -26.27M | -24.36M | -15.94M | -26.34M | -10.4M | -10.4M | -10.4M | n/a | -2.04M | -2.05M |
Owner Earnings | -363.58M | -296.18M | -304.94M | -319.7M | -349.56M | -370.16M | -392.5M | -422.62M | -416.94M | -402.98M | -379.05M | -373.43M | -360.96M | -381.77M | -399.74M | -361.72M | -361.87M | -332.3M | -297.58M | -282.85M | -239.09M | -207.47M |
Add to Watchlist
Select watchlists to add or remove IBRX